BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33273726)

  • 1. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
    Oncogene; 2021 Jan; 40(4):833-847. PubMed ID: 33273726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
    Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
    J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
    Zheng Z; Chen M; Xing P; Yan X; Xie B
    Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M6A RNA methylation-mediated dysregulation of AGAP2-AS1 promotes trastuzumab resistance of breast cancer.
    Cai Y; Zheng H; Xu D; Xie J; Wang W; Liu Z; Zheng Z
    Pharmacology; 2024 May; ():. PubMed ID: 38744264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.
    Qian X; Qu H; Zhang F; Peng S; Dou D; Yang Y; Ding Y; Xie M; Dong H; Liao Y; Han M
    Am J Cancer Res; 2021; 11(5):1962-1981. PubMed ID: 34094664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
    He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
    Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer.
    Wu H; Liu B; Chen Z; Li G; Zhang Z
    Cell Death Dis; 2020 Apr; 11(4):233. PubMed ID: 32300102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
    Zheng Y; Lu S; Xu Y; Zheng J
    Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction Note: MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
    Oncogene; 2023 Jul; 42(31):2415. PubMed ID: 37420031
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
    Wu M; Wen L; Zhou Y; Wu W
    Technol Cancer Res Treat; 2022; 21():15330338221085361. PubMed ID: 35369814
    [No Abstract]   [Full Text] [Related]  

  • 12. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
    Han M; Gu Y; Lu P; Li J; Cao H; Li X; Qian X; Yu C; Yang Y; Yang X; Han N; Dou D; Hu J; Dong H
    Mol Cancer; 2020 Feb; 19(1):26. PubMed ID: 32020881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
    Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
    Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N
    Xian J; Shang M; Dai Y; Wang Q; Long X; Li J; Cai Y; Xia C; Peng X
    J Dermatol Sci; 2022 Jan; 105(1):27-36. PubMed ID: 34930676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
    Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
    J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
    BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis.
    Guo Z; Liu X; Shao H
    Dig Liver Dis; 2022 Jul; 54(7):878-889. PubMed ID: 34838479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA AGAP2-AS1/miR-628-5p/PTN Axis Modulates Proliferation, Migration, Invasion, and Apoptosis of Glioma Cells.
    Yan Y; Wang Y; Liu Y; Chen T; Zhu Y; Li H; Kong F
    Cancer Manag Res; 2020; 12():6059-6068. PubMed ID: 32801858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA AGAP2-AS1 accelerates cell proliferation, migration, invasion and the EMT process in colorectal cancer via regulating the miR-4,668-3p/SRSF1 axis.
    Li H; Guo S; Zhang M; Li L; Wang F; Song B
    J Gene Med; 2020 Nov; 22(11):e3250. PubMed ID: 32639657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
    Hong S; Yan Z; Song Y; Bi M; Li S
    Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.